查詢結果分析
相關文獻
- Fungal Peritonitis in Peritoneal Dialysis Patients: Effect of Fluconazole Treatment and Use of the Twin-bag Disconnect System
- 腹膜透析併發再發性腹膜炎
- 連續可活動性腹膜透析自我效力量表之建立與測試
- 腹膜透析處方之臨床實用準則
- 腹膜透析處方之臨床實用準則
- 腹膜透析處方之臨床實用準則
- 腹膜透析處方之臨床實用準則
- 腹膜透析病患脫水不良之護理處置
- 腹膜透析的足量透析
- Combined CAVH and CAPD Therapy for Uremic Patients with Digoxin Intoxication--A Case Report
頁籤選單縮合
題名 | Fungal Peritonitis in Peritoneal Dialysis Patients: Effect of Fluconazole Treatment and Use of the Twin-bag Disconnect System=腹膜透析病人之徽菌性腹膜炎:Fluconazole治療及雙連袋分離系統使用之影響 |
---|---|
作者 | 陳志銘; 何茂旺; 余文良; 王任賢; | 書刊名 | 微免與感染雜誌 |
卷期 | 37:2 2004.04[民93.04] |
頁次 | 頁115-120 |
分類號 | 415.15 |
關鍵詞 | 腹膜透析; 徽菌性腹膜炎; Fluconazole治療; 雙連袋分離系統; Dialysis instrumentation; Fluconazole; Peritoneal dialysis; Peritonitis; |
語文 | 英文(English) |
英文摘要 | Fungal peritonitis is an uncommon but potentially life-threatening complication for patients undergoing continuous ambulatory peritoneal dialysis. This retrospective study evaluated the efficacy of fluconazole in fungal peritonitis treatment and the incidence of fungal peritonitis in different peritoneal dialysis disconnect systems. Fungal peritonitis was caused by Candida species in 67% of episodes. The most common pathogen in this series was Candida parapsilosis (29%), followed by Candida albicans (14%). One patient (5%) died within 1 month after admission for treatment of fungal peritonitis. Only 1 patient (5%) in this series could resume peritoneal dialysis. Treatment with fluconazole alone has an effect comparable to intraperitoneal (IP) amphotericin B alone or IP amphotericin B combined with oral or intravenous fluconazole. The incidence of fungal peritonitis in patients who used the spike, Y-set, and UV antiseptic systems was 5.69, 6.20, and 2.93 times, respectively, as frequent as that of fungal peritonitis in patients who used the twin-bag disconnect system. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。